PROMIS NEUROSCIENCES INC. Payments for (Proceeds from) Other Investing Activities
PROMIS NEUROSCIENCES INC. (PMN) reported Payments for (Proceeds from) Other Investing Activities of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2023-03-08
- PROMIS NEUROSCIENCES INC. payments for (proceeds from) other investing activities for the quarter ending 2021-12-31 was -$2.36K.
- PROMIS NEUROSCIENCES INC. payments for (proceeds from) other investing activities for the quarter ending 2021-09-30 was $2.37K.
- PROMIS NEUROSCIENCES INC. payments for (proceeds from) other investing activities for fiscal 2021 was -$2.36K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | -$2.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $12.00 derived: sum of 2 quarters · filed 2023-03-08 | -$2.36K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $2.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$2.37K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |